Search for: "Janssen Pharmaceuticals Inc." Results 1 - 20 of 194
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 Mar 2016, 8:00 am by Robert Kreisman
The federal district court has entered a ruling that Janssen Pharmaceuticals Inc. should pay penalties for violating South Carolina law. [read post]
4 Jan 2016, 7:49 am by Law Offices of Jeffrey S. Glassman
Ortho-McNeil-Janssen Pharma., Inc: Defective Drug Lawsuits appeared first on Product Liability Lawyer Blog. [read post]
15 Nov 2018, 9:28 am by Jordan Ross
New Jersey’s Attorney General filed a lawsuit Tuesday against Janssen Pharmaceuticals, Inc., a subsidiary of Johnson & Johnson, for misleading patients and prescribers about the addictive risks associated with the use of its drugs. [read post]
1 Nov 2015, 9:57 pm by Patent Docs
Par Pharmaceutical Inc. et al. 1:15-cv-00679; filed August 3, 2015 in the District Court of Delaware • Plaintiffs: Janssen Biotech Inc.; Janssen Oncology Inc.; Janssen Research & Development LLC • Defendants: Amneal Pharmaceuticals LLC; Amneal Pharmaceuticals of New York LLC; Par Pharmaceutical Inc.; Par Pharmaceutical Companies Inc. [read post]
29 Dec 2013, 9:15 pm by Patent Docs
Janssen Pharmaceuticals Inc. et al. v. [read post]
18 May 2014, 8:42 pm by Patent Docs
Mylan Pharmaceuticals Inc. et al. 1:14-cv-00594; filed May 12, 2014 in the District Court of Delaware • Plaintiffs: Alza Corp.; Janssen Pharmaceuticals Inc. [read post]
14 Jun 2015, 8:59 pm by Patent Docs
Janssen Pharmaceuticals Inc. v. [read post]
14 Nov 2013, 5:00 am
Janssen Pharmaceuticals, Inc., a New Jersey pharmaceutical company of J&J, provides medicines for attention deficit hyperactivity disorder (ADHD), general medicine (acid reflux disease, infectious diseases), mental health (bipolar I disorder, schizophrenia), neurologics (Alzheimer’s disease, epilepsy, migraine prevention and treatment), pain management, and women’s health. [read post]
15 Apr 2009, 8:56 pm
By Suresh Pillai -- Resolution Announced in Johnson & Johnson Razadyne ® ER Patent Litigation Johnson & Johnson units Janssen LP, Janssen Pharmaceutica NV, and Ortho-McNeil Neurologics have stipulated to a dismissal with prejudice of all claims of patent infringement against KV Pharmaceutical Co., Barr Pharmaceuticals Inc., and Sandoz Inc. with respect to a generic version of Razadyne ® ER. [read post]
23 May 2012, 9:22 pm by Patent Docs
Searle, LLC • Defendants: Lupin Ltd.; Lupin Pharmaceuticals Inc. [read post]
23 May 2011, 9:59 pm by Patent Docs
Impax Laboratories, Inc. et al. 1:11-cv-00395; filed May 5, 2011 in the District Court of Delaware • Plaintiffs: Alza Corp.; Ortho-McNeil-Janssen Pharmaceuticals, Inc. • Defendants: Impax Laboratories, Inc.; Teva Pharmaceuticals USA, Inc.; Teva Pharmaceutical Industries Ltd. [read post]
17 Jun 2012, 9:55 pm by Patent Docs
Searle, LLC • Defendants: Hetero Drugs, Ltd., Unit III; Invagen Pharmaceuticals, Inc. [read post]
29 Apr 2010, 2:06 am by Ben Vernia
“The Corporate Integrity Agreement requires Ortho-McNeil-Janssen-Pharmaceuticals, Inc. to increase transparency and accountability and to make changes designed to avoid illegal drug promotion in the future.” [read post]
4 Nov 2013, 3:04 am by Ben Vernia
On November 4, the Department of Justice announced that Johnson & Johnson and its subsidiaries, Janssen Pharmaceuticals, Inc., and Scios, Inc., had agreed to pay $2.2 billion to resolve claims originally brought by whistleblowers that the company promoted its drugs Risperdal, Invega, and Natrecor for unapproved (off-label) uses. [read post]
31 Aug 2016, 1:31 pm by ccladm
Janssen Pharmaceuticals, Inc. on May 11th, and ruled that Janssen neglected to make an effort to warn physicians of the risks regarding Topamax. [read post]
31 Aug 2016, 1:31 pm by ccladm
Janssen Pharmaceuticals, Inc. on May 11th, and ruled that Janssen neglected to make an effort to warn physicians of the risks regarding Topamax. [read post]
23 Feb 2010, 9:01 pm by Patent Docs
By Suresh Pillai -- Lupin Claims Tri-Cyclen® Patent Invalid Lupin Pharmaceuticals Inc. has filed counterclaims in its suit with Ortho-McNeil-Janssen Pharmaceuticals Inc., alleging that Ortho's patent covering its Tri-Cyclen® Lo contraceptive, U.S. [read post]